Immunoexpression of p62/SQSTM1/Sequestosome‑1 in human primary and recurrent IDH1/2 wild‑type glioblastoma: A pilot studyAntonio Ieni, Giovanni Tuccari, Giuseppe Broggi et al.|Oncology Letters|2022Cited by 7